Optimization of Rutaecarpine as ABCA1 Up-Regulator for Treating Atherosclerosis

ACS Med Chem Lett. 2014 Jun 24;5(8):884-8. doi: 10.1021/ml500131a. eCollection 2014 Aug 14.

Abstract

ATP-binding cassette transporter A1 (ABCA1) is a key transporter and receptor in promoting cholesterol efflux, and increasing the expression level of ABCA1 is antiatherogenic. In our previous study, rutaecarpine (RUT) was found to protect ApoE(-/-) mice from developing atherosclerosis through preferentially up-regulating ABCA1 expression. In the present work, a series of RUT derivatives were synthesized and examined as ABCA1 expression up-regulators. Compounds CD1, CD6, and BCD1-2 were found to possess the most potential activity as antiatherosclerotic agents among all compounds tested.

Keywords: ABCA1; RCT; Rutaecarpine; atherosclerosis.